|
| Friday, July 13, 2018 |
|
|
Scientists Discover the Tuberal Nucleus' Role in Controlling Appetite and Body Weight |
| Researchers at A*STAR's Singapore Bioimaging Consortium (SBIC) have identified a new region of the mouse brain called the Tuberal Nucleus (TN), which affects appetite and body weight. more info >> |
|
| Thursday, June 8, 2017 |
|
|
Human Heart Tissue Grown from Stem Cells Improves Drug Testing |
| Researchers at the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR have engineered a three-dimensional heart tissue from human stem cells to test the safety and efficacy of new drugs on the heart. more info >> |
|
| Thursday, December 8, 2016 |
|
|
NovogeneAIT Singapore and the Genome Institute of Singapore Forge Public-Private Partnership to Establish Whole Genome Sequencing Centre in Singapore |
| NovogeneAIT Genomics Singapore (NovogeneAIT) - a new joint venture between Novogene and AITbiotech - will establish a joint whole genome sequencing (WGS) centre at Biopolis, Singapore. more info >> |
|
| Monday, November 21, 2016 |
|
|
Scientists Successfully Create Blood from Skin Cells |
| Researchers in Singapore have artificially generated new mouse blood and immune cells from skin cells. This is a significant first step towards the eventual goal: the engineering of new human blood cells from skin cells or other artificial sources. more info >> |
|
| Tuesday, September 13, 2016 |
|
|
Singapore Scientists Develop DNA-altering Technology to Tackle Diseases |
| Researchers in Singapore have developed a new protein that can alter DNA in living cells with much higher precision than current methods. more info >> |
|
| Friday, July 29, 2016 |
|
|
Singapore Scientists Grow Mini Human Brains |
| Scientists in Singapore have made a big leap on research on the 'mini-brain'. These advanced mini versions of the human midbrain will help researchers develop treatments and conduct other studies into Parkinson's Disease[1] (PD) and ageing-related brain diseases. more info >> |
|
| Wednesday, July 20, 2016 |
|
|
A*STAR and MSD Establish a New Research Collaboration to Advance Peptide Therapeutics |
| Singapore's Agency for Science, Technology and Research (A*STAR) and MSD (known as Merck & Co., Inc., in U.S.A. and Canada) have formed a two-year collaboration aimed at improving cellular delivery of macrocyclic peptides, a class of molecules that can potentially access therapeutic strategies that have been refractory to traditional approaches. more info >> |
|
| Monday, July 18, 2016 |
|
|
Singapore Scientists Discover New Pathways Leading to Cancer Progression |
| Scientists from A*STAR's Genome Institute of Singapore and the Cancer Science Institute of Singapore at the National University of Singapore came together to understand how EZH2, a cancer-promoting gene which is known to be involved in many types of cancers, is activated in breast cancer and lymphomas. more info >> |
|
| Wednesday, July 13, 2016 |
|
|
Study Finds Strong Genetic Risk Factor for Kidney Disease |
| An international research collaboration has discovered a strong genetic risk factor for IgA nephropathy (IgAN) - the most common inflammatory kidney disease worldwide - and related renal dysfunction. more info >> |
|
| Tuesday, July 12, 2016 |
|
|
A New Way to Diagnose and Treat Lung Cancer |
| A team of researchers from Singapore has discovered a class of small RNA molecules, known as oncomiRs, which are responsible for fuelling lung cancer. more info >> |
|
|
|
